DISSECTION Trial
William Brinkman, M.D., Principal Investigator
Sponsored by Medtronic, the purpose of this study is to evaluate the safety and effectiveness of the Valiant Thoracic Stent Graft System in the treatment of acute, complicated Type B aortic dissections (a tear in the lining of the aorta) in the section of the aorta that lies in the chest. The OPTION Trial – David O. Moore, M.D., and Lonnie Ginn, P.A., Principal Investigators icon for option trial